Catenae Innovation PLC announced that it has signed a collaboration agreement with ProMake Limited ("ProMake"), a global specialist in material science and medical innovations. Under the terms of the agreement, Catenae will be the exclusive provider of data management services to ProMake to fulfil its position on the Public Health England ("PHE") National Microbiology Framework. ProMake has unique intellectual property and technology that utilises graphene and other nano-materials within an injection moulded 'PreVent' tube, which a patient blows into in order to provide medical samples. The test may be used to diagnose many different diseases using a much less invasive method and at a potentially lower cost to conventional methods. Initially, the PreVent tube will be processed in a lab but ProMake's aim is to build an inexpensive 'Bio-Pod' device that will analyse the sample locally and pass data to a cloud based platform for diagnosis via an individual's mobile app. The National Microbiology Framework, announced by PHE in November 2020, supports the newly formed UK Health Security Agency (UKHSA) and the Government's effort to provide a broad range of medical testing and diagnostic services for people in the UK. Under this collaboration agreement, Catenae will also provide consulting services to support ProMake in its engagement with the organizations able to access the Framework Agreement, which includes: Public Health England; Department of Health and Social Care; Public Health Wales; Public Health Scotland; Department for Health for Northern Ireland; Health and Social Care Northern Ireland; NHS Authorities, NHS Trusts, NHS Foundation Trusts, Special Health Authorities, NHS Scotland Health Boards, NHS Wales Health Boards, NHS Northern Ireland Health Boards, Special NHS Boards and any other NHS entity; Local Authorities; Any other bodies governed by public law (as defined in regulation 2 of the Public Contracts Regulations 2015 (SI 2015/102) (as amended); and Academic or charitable institutions (including any such institutions that are not Contracting Authorities). The Catenae Board considers that it is premature to provide any guidance as to the timing or value to Catenae of this collaboration, but anticipates being able to give a more detailed update in the coming months.